Artinger EL, Mishra BP, Zaffuto KM, Li BE, Chung EK, Moore AW, Chen Y, Cheng C, Ernst P. 2013. An MLLdependent network sustains hematopoiesis. PNAS 110:12000–12005. DOI: https://doi.org/10.1073/pnas. 1301278110, PMID: 23744037
Au YZ, Gu M, De Braekeleer E, Gozdecka M, Aspris D, Tarumoto Y, Cooper J, Yu J, Ong SH, Chen X, Tzelepis K, Huntly BJP, Vassiliou G, Yusa K. 2020. KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements. Leukemia 35:1012–1022. DOI: https://doi.org/10.1038/s41375-020-1001-z, PMID: 32764680
Avvakumov N, Lalonde ME, Saksouk N, Paquet E, Glass KC, Landry AJ, Doyon Y, Cayrou C, Robitaille GA, Richard DE, Yang XJ, Kutateladze TG, Coˆ te´ J. 2012. Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation. Molecular and Cellular Biology 32:689–703. DOI: https://doi.org/10.1128/MCB.06455-11, PMID: 22144582
Ayton PM, Chen EH, Cleary ML. 2004. Binding to nonmethylated CpG DNA is essential for target recognition, Transactivation, and myeloid transformation by an MLL oncoprotein. Molecular and Cellular Biology 24:10470– 10478. DOI: https://doi.org/10.1128/MCB.24.23.10470-10478.2004, PMID: 15542854
Birke M, Schreiner S, Garcı´a-Cue´ llar MP, Mahr K, Titgemeyer F, Slany RK. 2002. The MT domain of the protooncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. Nucleic Acids Research 30:958–965. DOI: https://doi.org/10.1093/nar/30.4.958, PMID: 11842107
Champagne KS, Saksouk N, Pen˜ a PV, Johnson K, Ullah M, Yang XJ, Coˆ te´ J, Kutateladze TG. 2008. The crystal structure of the ING5 PHD finger in complex with an H3K4me3 histone peptide. Proteins: Structure, Function, and Bioinformatics 72:1371–1376. DOI: https://doi.org/10.1002/prot.22140, PMID: 18623064
DiMartino JF, Miller T, Ayton PM, Landewe T, Hess JL, Cleary ML, Shilatifard A. 2000. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. Blood 96: 3887–3893. DOI: https://doi.org/10.1182/blood.V96.12.3887, PMID: 11090074
Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. 1998. A third-generation Lentivirus vector with a conditional packaging system. Journal of Virology 72:8463–8471. DOI: https://doi.org/10.1128/JVI.72. 11.8463-8471.1998, PMID: 9765382
Erb MA, Scott TG, Li BE, Xie H, Paulk J, Seo HS, Souza A, Roberts JM, Dastjerdi S, Buckley DL, Sanjana NE, Shalem O, Nabet B, Zeid R, Offei-Addo NK, Dhe-Paganon S, Zhang F, Orkin SH, Winter GE, Bradner JE. 2017. Transcription control by the ENL YEATS domain in acute leukaemia. Nature 543:270–274. DOI: https://doi.org/ 10.1038/nature21688, PMID: 28241139
Foy RL, Song IY, Chitalia VC, Cohen HT, Saksouk N, Cayrou C, Vaziri C, Coˆ te´ J, Panchenko MV. 2008. Role of Jade-1 in the histone acetyltransferase (HAT) HBO1 complex. Journal of Biological Chemistry 283:28817– 28826. DOI: https://doi.org/10.1074/jbc.M801407200, PMID: 18684714
Goodfellow SJ, Zomerdijk JC. 2013. Basic mechanisms in RNA polymerase I transcription of the ribosomal RNA genes. Sub-Cellular Biochemistry 61:211–236. DOI: https://doi.org/10.1007/978-94-007-4525-4_10, PMID: 23150253
Gough SM, Slape CI, Aplan PD. 2011. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 118:6247–6257. DOI: https://doi.org/10.1182/blood-2011-07-328880, PMID: 21948299
Hayashi Y, Harada Y, Kagiyama Y, Nishikawa S, Ding Y, Imagawa J, Shingai N, Kato N, Kitaura J, Hokaiwado S, Maemoto Y, Ito A, Matsui H, Kitabayashi I, Iwama A, Komatsu N, Kitamura T, Harada H. 2019. NUP98-HBO1- fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesis. Blood Advances 3:1047–1060. DOI: https://doi.org/10.1182/bloodadvances.2018025007, PMID: 30944097
Heckl D, Kowalczyk MS, Yudovich D, Belizaire R, Puram RV, McConkey ME, Thielke A, Aster JC, Regev A, Ebert BL. 2014. Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPRCas9 genome editing. Nature Biotechnology 32:941–946. DOI: https://doi.org/10.1038/nbt.2951, PMID: 24952 903
Kaltenbach S, Soler G, Barin C, Gervais C, Bernard OA, Penard-Lacronique V, Romana SP. 2010. NUP98-MLL fusion in human acute myeloblastic leukemia. Blood 116:2332–2335. DOI: https://doi.org/10.1182/blood-2010- 04-277806, PMID: 20558618
Klossowski S, Miao H, Kempinska K, Wu T, Purohit T, Kim E, Linhares BM, Chen D, Jih G, Perkey E, Huang H, He M, Wen B, Wang Y, Yu K, Lee SC-W, Danet-Desnoyers G, Trotman W, Kandarpa M, Cotton A, et al. 2019. Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. Journal of Clinical Investigation 130:981–997. DOI: https://doi.org/10.1172/JCI129126
Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, Golub TR, Armstrong SA. 2006. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442:818–822. DOI: https://doi.org/10.1038/nature04980, PMID: 16862118
Krivtsov AV, Evans K, Gadrey JY, Eschle BK, Hatton C, Uckelmann HJ, Ross KN, Perner F, Olsen SN, Pritchard T, McDermott L, Jones CD, Jing D, Braytee A, Chacon D, Earley E, McKeever BM, Claremon D, Gifford AJ, Lee HJ, et al. 2019. A Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-Rearranged leukemia. Cancer Cell 36:660–673. DOI: https://doi.org/10.1016/j.ccell.2019.11.001, PMID: 31 821784
Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G. 2001. NUP98-HOXA9 expression in Hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. The EMBO Journal 20:350–361. DOI: https://doi.org/10.1093/emboj/20.3.350, PMID: 11157742
Lalonde ME, Avvakumov N, Glass KC, Joncas FH, Saksouk N, Holliday M, Paquet E, Yan K, Tong Q, Klein BJ, Tan S, Yang XJ, Kutateladze TG, Coˆ te´ J. 2013. Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity. Genes & Development 27:2009–2024. DOI: https://doi.org/10.1101/ gad.223396.113, PMID: 24065767
Lavau C, Szilvassy SJ, Slany R, Cleary ML. 1997. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. The EMBO Journal 16:4226–4237. DOI: https:// doi.org/10.1093/emboj/16.14.4226, PMID: 9250666
Li Y, Wen H, Xi Y, Tanaka K, Wang H, Peng D, Ren Y, Jin Q, Dent SY, Li W, Li H, Shi X. 2014. AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79 methylation. Cell 159:558–571. DOI: https://doi.org/10. 1016/j.cell.2014.09.049, PMID: 25417107
Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754–1760. DOI: https://doi.org/10.1093/bioinformatics/btp324, PMID: 19451168 Liedtke M, Ayton PM, Somervaille TC, Smith KS, Cleary ML. 2010. Self-association mediated by the ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6. Blood 116:63–70. DOI: https://doi. org/10.1182/blood-2009-09-243386, PMID: 20395419
Lin C, Smith ER, Takahashi H, Lai KC, Martin-Brown S, Florens L, Washburn MP, Conaway JW, Conaway RC, Shilatifard A. 2010. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Molecular Cell 37:429–437. DOI: https://doi.org/10. 1016/j.molcel.2010.01.026, PMID: 20159561
Luo RT, Lavau C, Du C, Simone F, Polak PE, Kawamata S, Thirman MJ. 2001. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis. Molecular and Cellular Biology 21:5678–5687. DOI: https://doi.org/10.1128/MCB.21.16.5678- 5687.2001, PMID: 11463848
MacPherson L, Anokye J, Yeung MM, Lam EYN, Chan YC, Weng CF, Yeh P, Knezevic K, Butler MS, Hoegl A, Chan KL, Burr ML, Gearing LJ, Willson T, Liu J, Choi J, Yang Y, Bilardi RA, Falk H, Nguyen N, et al. 2020. HBO1 is required for the maintenance of leukaemia stem cells. Nature 577:266–270. DOI: https://doi.org/10.1038/ s41586-019-1835-6, PMID: 31827282
Martin M. 2011. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17:10–12. DOI: https://doi.org/10.14806/ej.17.1.200
Meyer C, Burmeister T, Gro¨ ger D, Tsaur G, Fechina L, Renneville A, Sutton R, Venn NC, Emerenciano M, Pombode-Oliveira MS, Barbieri Blunck C, Almeida Lopes B, Zuna J, Trka J, Ballerini P, Lapillonne H, De Braekeleer M, Cazzaniga G, Corral Abascal L, van der Velden VHJ, et al. 2018. The MLL recombinome of acute leukemias in 2017. Leukemia 32:273–284. DOI: https://doi.org/10.1038/leu.2017.213, PMID: 28701730
Milne TA, Kim J, Wang GG, Stadler SC, Basrur V, Whitcomb SJ, Wang Z, Ruthenburg AJ, Elenitoba-Johnson KS, Roeder RG, Allis CD. 2010. Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis. Molecular Cell 38:853–863. DOI: https://doi.org/10.1016/j.molcel.2010.05.011, PMID: 20541448
Mishima Y, Miyagi S, Saraya A, Negishi M, Endoh M, Endo TA, Toyoda T, Shinga J, Katsumoto T, Chiba T, Yamaguchi N, Kitabayashi I, Koseki H, Iwama A. 2011. The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis. Blood 118:2443–2453. DOI: https://doi.org/10. 1182/blood-2011-01-331892, PMID: 21753189
Miyamoto R, Okuda H, Kanai A, Takahashi S, Kawamura T, Matsui H, Kitamura T, Kitabayashi I, Inaba T, Yokoyama A. 2020. Activation of CpG-Rich promoters mediated by MLL drives MOZ-Rearranged leukemia. Cell Reports 32:108200. DOI: https://doi.org/10.1016/j.celrep.2020.108200, PMID: 32997997
Miyamoto R, Yokoyama A. 2021. Protocol for fractionation-assisted native ChIP (fanChIP) to capture proteinprotein/DNA interactions on chromatin. STAR Protocols 2:100404. DOI: https://doi.org/10.1016/j.xpro.2021. 100404, PMID: 33855306
Morita S, Kojima T, Kitamura T. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Therapy 7:1063–1066. DOI: https://doi.org/10.1038/sj.gt.3301206, PMID: 10871756
Nagase T, Yamakawa H, Tadokoro S, Nakajima D, Inoue S, Yamaguchi K, Itokawa Y, Kikuno RF, Koga H, Ohara O. 2008. Exploration of human ORFeome: high-throughput preparation of ORF clones and efficient characterization of their protein products. DNA Research 15:137–149. DOI: https://doi.org/10.1093/dnares/ dsn004, PMID: 18316326
Okuda H, Kawaguchi M, Kanai A, Matsui H, Kawamura T, Inaba T, Kitabayashi I, Yokoyama A. 2014. MLL fusion proteins link transcriptional coactivators to previously active CpG-rich promoters. Nucleic Acids Research 42: 4241–4256. DOI: https://doi.org/10.1093/nar/gkt1394, PMID: 24465000
Okuda H, Kanai A, Ito S, Matsui H, Yokoyama A. 2015. AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription. Nature Communications 6:8869. DOI: https://doi.org/10. 1038/ncomms9869, PMID: 26593443
Okuda H, Takahashi S, Takaori-Kondo A, Yokoyama A. 2016. TBP loading by AF4 through SL1 is the major ratelimiting step in MLL fusion-dependent transcription. Cell Cycle 15:2712–2722. DOI: https://doi.org/10.1080/ 15384101.2016.1222337, PMID: 27564129
Okuda H, Stanojevic B, Kanai A, Kawamura T, Takahashi S, Matsui H, Takaori-Kondo A, Yokoyama A. 2017. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia. Journal of Clinical Investigation 127:1918–1931. DOI: https://doi.org/10.1172/JCI91406, PMID: 28394257
Okuda H, Yokoyama A. 2017a. In vivo leukemogenesis model using retrovirus transduction. Bio-Protocol 7: BioProtoc.2627. DOI: https://doi.org/10.21769/BioProtoc.2627
Okuda H, Yokoyama A. 2017b. Myeloid progenitor transformation assay. Bio-Protocol 7:BioProtoc.2626. DOI: https://doi.org/10.21769/BioProtoc.2626
Pradeepa MM, Sutherland HG, Ule J, Grimes GR, Bickmore WA. 2012. Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLOS Genetics 8: e1002717. DOI: https://doi.org/10.1371/journal.pgen.1002717, PMID: 22615581
Qi S, Li Z, Schulze-Gahmen U, Stjepanovic G, Zhou Q, Hurley JH. 2017. Structural basis for ELL2 and AFF4 activation of HIV-1 proviral transcription. Nature Communications 8:14076. DOI: https://doi.org/10.1038/ ncomms14076, PMID: 28134250
Shi A, Murai MJ, He S, Lund G, Hartley T, Purohit T, Reddy G, Chruszcz M, Grembecka J, Cierpicki T. 2012. Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia. Blood 120:4461–4469. DOI: https://doi.org/10.1182/blood-2012-05-429274, PMID: 22936661
Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW. 1996. An RNA polymerase II elongation factor encoded by the human ELL gene. Science 271:1873–1876. DOI: https://doi.org/10.1126/science.271.5257. 1873, PMID: 8596958
Shima Y, Yumoto M, Katsumoto T, Kitabayashi I. 2017. MLL is essential for NUP98-HOXA9-induced leukemia. Leukemia 31:2200–2210. DOI: https://doi.org/10.1038/leu.2017.62, PMID: 28210005
Simone F, Polak PE, Kaberlein JJ, Luo RT, Levitan DA, Thirman MJ. 2001. EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein. Blood 98:201–209. DOI: https://doi.org/10. 1182/blood.V98.1.201, PMID: 11418481
Simone F, Luo RT, Polak PE, Kaberlein JJ, Thirman MJ. 2003. ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood 101:2355–2362. DOI: https://doi.org/10.1182/ blood-2002-06-1664, PMID: 12446457
Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD. 2003. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9: 493–501. DOI: https://doi.org/10.1261/rna.2192803, PMID: 12649500 Takahashi H, Parmely TJ, Sato S, Tomomori-Sato C, Banks CA, Kong SE, Szutorisz H, Swanson SK, Martin-Brown S, Washburn MP, Florens L, Seidel CW, Lin C, Smith ER, Shilatifard A, Conaway RC, Conaway JW. 2011. Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 146:92–104. DOI: https://doi.org/10.1016/j.cell.2011.06.005, PMID: 21729782
Takahashi S, Yokoyama A. 2020. The molecular functions of common and atypical MLL fusion protein complexes. Biochimica Et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1863:194548. DOI: https://doi.org/10. 1016/j.bbagrm.2020.194548, PMID: 32320750
Thorvaldsdo´ ttir H, Robinson JT, Mesirov JP. 2013. Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Briefings in Bioinformatics 14:178–192. DOI: https://doi.org/10. 1093/bib/bbs017, PMID: 22517427
Tkachuk DC, Kohler S, Cleary ML. 1992. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691–700. DOI: https://doi.org/10.1016/0092-8674(92) 90602-9, PMID: 1423624
Tzelepis K, Koike-Yusa H, De Braekeleer E, Li Y, Metzakopian E, Dovey OM, Mupo A, Grinkevich V, Li M, Mazan M, Gozdecka M, Ohnishi S, Cooper J, Patel M, McKerrell T, Chen B, Domingues AF, Gallipoli P, Teichmann S, Ponstingl H, et al. 2016. A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Reports 17:1193–1205. DOI: https://doi.org/10.1016/j.celrep.2016.09.079, PMID: 27760321
van Nuland R, van Schaik FM, Simonis M, van Heesch S, Cuppen E, Boelens R, Timmers HM, van Ingen H. 2013. Nucleosomal DNA binding drives the recognition of H3K36-methylated nucleosomes by the PSIP1-PWWP domain. Epigenetics & Chromatin 6:12. DOI: https://doi.org/10.1186/1756-8935-6-12, PMID: 23656834
Wan L, Wen H, Li Y, Lyu J, Xi Y, Hoshii T, Joseph JK, Wang X, Loh YE, Erb MA, Souza AL, Bradner JE, Shen L, Li W, Li H, Allis CD, Armstrong SA, Shi X. 2017. ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia. Nature 543:265–269. DOI: https://doi.org/10.1038/nature21687, PMID: 28241141
Wang GG, Cai L, Pasillas MP, Kamps MP. 2007. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nature Cell Biology 9:804–812. DOI: https://doi.org/10.1038/ncb1608, PMID: 17589499
Wang Z, Song J, Milne TA, Wang GG, Li H, Allis CD, Patel DJ. 2010. Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression. Cell 141:1183–1194. DOI: https://doi.org/10.1016/j.cell.2010.05.016, PMID: 20541251
Wiederschain D, Kawai H, Gu J, Shilatifard A, Yuan ZM. 2003. Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. Molecular and Cellular Biology 23:4230–4246. DOI: https://doi.org/10.1128/ MCB.23.12.4230-4246.2003, PMID: 12773566
Xu H, Valerio DG, Eisold ME, Sinha A, Koche RP, Hu W, Chen CW, Chu SH, Brien GL, Park CY, Hsieh JJ, Ernst P, Armstrong SA. 2016. NUP98 fusion proteins interact with the NSL and MLL1 complexes to drive leukemogenesis. Cancer Cell 30:863–878. DOI: https://doi.org/10.1016/j.ccell.2016.10.019, PMID: 27889185
Yokoyama A, Kitabayashi I, Ayton PM, Cleary ML, Ohki M. 2002. Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood 100:3710–3718. DOI: https://doi.org/10.1182/blood-2002-04-1015, PMID: 12393701
Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W, Cleary ML. 2004. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with Menin to regulate hox gene expression. Molecular and Cellular Biology 24:5639–5649. DOI: https://doi.org/10.1128/MCB.24.13.5639-5649. 2004, PMID: 15199122
Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML. 2005. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123:207–218. DOI: https://doi.org/10.1016/j.cell.2005.09.025, PMID: 16239140
Yokoyama A, Lin M, Naresh A, Kitabayashi I, Cleary ML. 2010. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. Cancer Cell 17: 198–212. DOI: https://doi.org/10.1016/j.ccr.2009.12.040, PMID: 20153263
Yokoyama A, Cleary ML. 2008. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14:36–46. DOI: https://doi.org/10.1016/j.ccr.2008.05.003, PMID: 18598942
Yu BD, Hanson RD, Hess JL, Horning SE, Korsmeyer SJ. 1998. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis. PNAS 95:10632–10636. DOI: https://doi.org/10. 1073/pnas.95.18.10632, PMID: 9724755
Zhang Y, Guo Y, Gough SM, Zhang J, Vann KR, Li K, Cai L, Shi X, Aplan PD, Wang GG, Kutateladze TG. 2020. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion. Nature Communications 11: 3339. DOI: https://doi.org/10.1038/s41467-020-17098-4, PMID: 32620764
論文の公開元へ
